News Wire

The FDA is aiming to approve drugs based on very early data if the medication shows a possible benefit in terms of survival, the head of the agency told lawmakers at a House committee hearing. Speaking before the House Committee on Energy and Commerce, FDA Commissioner Scott Gottlieb, MD, said the agency…
Fremanezumab (Teva Pharmaceuticals), an immunotherapy that counteracts a molecule released during migraine, reduced the number of days that chronic migraine sufferers experienced headaches in phase 3 trial results published by the New England Journal of Medicine. The World Health Organization estimates…
Diabetes costs employers about $20 billion a year thanks to about 57 million unplanned sick days for workers, according to a report by Gallop and Sharecare, a health and wellness engagement company. The prevalence of diabetes in the adult population grew, from 10.6% in 2008 to 11.6% in 2016. It was…
Many patients with private insurance who are taken to the hospital by ambulance also feel that they are being taken to the cleaners. An investigation by Kaiser Health News (KHN) finds patients are stuck with exorbitant out-of-network bills because the ambulance companies and insurers had not hammered…
Electronic health records (EHRs) are causing “alert fatigue.” They send so many prescribing alerts that health care providers often override them, according to a study in the Journal of the American Medical Informatics Association. Unfortunately, the overrides occur even for important drugs. “Almost…
It’s not the amount of fat in your body but where it’s stored that may increase your risk for heart attack, stroke, and diabetes, according to new research. The study, presented at the annual meeting of the Radiological Society of North America (RSNA), looked at the differences in fat distribution…
Neither dose of AM-111 (Auris Medical Holding) led to a statistically significant improvement in hearing among patients with severe to profound sudden deafness in the HEALOS phase 3 clinical trial, the company says. However, one subgroup did show a benefit. Auris announced that top-line results from…
Government and industry efforts since 2003 to phase out chemicals used to make nonstick coatings, such as Teflon, have prevented more than 118,000 low-weight births and related brain damage in the United States. This is the main finding of a new report—based on analysis of new mothers’ blood samples…
An estimated one in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from the World Health Organization (WHO). This means that people are taking medicines that fail to treat or prevent disease. Not only is this a waste…
New research indicates that the prevalence of arthritis in the United States has been substantially underestimated, especially among adults younger than 65 years of age. The findings, published in the journal Arthritis & Rheumatology, indicate that research is needed to better monitor arthritis prevalence…
Changing the prices of seven foods, including fruits, vegetables, and sugar-sweetened beverages, could reduce deaths due to stroke, diabetes, and cardiovascular disease and address health disparities in the United States, according to a study led by Tufts University researchers. In the study, published…
The FDA has approved the first implantable lens that can be adjusted after cataract surgery using ultraviolet light to improve patients’ vision, possibly eliminating the need for eyeglasses or contacts. The Light Adjustable Lens (RxSight Inc.) is made of a unique material that reacts to ultraviolet…
Aetna wants to combine with CVS Health and the Cleveland Clinic is teaming up with Oscar Health. Two developments that Managed Care’s covered (here and here). The New York Times today says that the joining of health plans, providers, and national drug store chains reflects the growing uncertainty…
Funding for the Children’s Health Insurance Program (CHIP) is in danger of running out in nearly a dozen states, the Washington Post reports. About nine million children are insured through CHIP, and an additional 370,000 pregnant women also get their coverage through the program. The crisis results…
The FDA has approved the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of the three or more drugs included in standard HIV treatment. Juluca (dolutegravir/rilpivirine, ViiV Healthcare) is a fixed-dose tablet…

Pages